
Asia-Pacific markets set to open mixed as investors digest Trump-Xi call
The view of Nanjing Road East Pedestrian Mall, the main shopping street in Shanghai.
Bruce Yuanyue Bi | The Image Bank | Getty Images
Asia-Pacific markets were set to trade mixed Friday as investors assessed the phone call between U.S. President Donald Trump and Chinese President Xi Jinping.
Trump and Xi spoke on Thursday and agreed that officials from the U.S. and China will meet soon to continue negotiations aimed at ending the ongoing trade war.
Trump said he had a "very good" call with Xi for about 90 minutes, which focused "almost entirely" on trade.
The call yielded a "very positive conclusion for both Countries," Trump wrote in a Truth Social post.
Japan's benchmark Nikkei 225 was set to fall at the open, with the futures contract in Chicago at 37,460 while its counterpart in Osaka last traded at 37,440 against the index's Thursday close of 37,554.49.
Futures for Hong Kong's Hang Seng Index stood at 23,822, pointing to a lower open. The Hang Seng Index had closed at 23,906.97 in the previous session.
Australia's S&P/ASX 200 was set to start the day slightly higher, with futures tied to the benchmark at 8,540, compared to its last close of 8,538.9.
"The U.S.‑China agreement to de‑escalate tensions, and the recent phone call between Trump and Xi, shows both countries have an economic 'pain threshold," said Luke Yeaman, chief economist and head of global economics and markets research at Commonwealth Bank.
While the call takes some severe downside scenarios off the table, tensions will remain high and more bouts of escalation are still on the cards, Yeaman wrote in a note published Friday. "In the longer term, both will continue to push for more economic independence."
U.S. futures were mostly calm ahead of a key jobs report that is expected to shed light on the health of the U.S. economy.
Overnight stateside, the three major averages closed lower. The S&P 500 fell, spurred by a drop in shares of electric vehicle maker Tesla. The broad market index dipped 0.53% and closed at 5,939.30, while the Nasdaq Composite pulled back 0.83% to end at 19,298.45. The Dow Jones Industrial Average dropped 108 points, or 0.25%, to settle at 42,319.74.
— CNBC's Pia Singh and Sean Conlon contributed to this report.
The three leading indexes finished Thursday's session in the red.
The S&P 500 plummeted 0.53% to close at 5,939.30, while the Nasdaq Composite declined 0.83%, ending at 19,298.45. The Dow Jones Industrial Average shed 108 points, or 0.25%, to finish at 42,319.74.
— Sean Conlon
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
CRISPR Therapeutics (NasdaqGM:CRSP) Sees 16% Stock Price Surge Over Last Month
CRISPR Therapeutics experienced a 15.8% increase in its share price over the past month. While specific recent news on the company was not available to credit for this movement, it's worth noting that during this period, the broader market rose by 1.8%, and has seen a 13% increase over the past year. With market earnings projected to grow 14% annually, the strong performance of CRISPR's stock could be viewed alongside these generally positive trends and any recent but unspecified developments as contributing factors to its upward momentum in the market. Be aware that CRISPR Therapeutics is showing 1 weakness in our investment analysis. Trump's oil boom is here — pipelines are primed to profit. Discover the 22 US stocks riding the wave. Over the past year, CRISPR Therapeutics' shares experienced a total return of 27.67% decline. This longer-term performance contrasts with the U.S. market's return of 12.6% and the U.S. Biotechs industry return of 9% over the same period. Despite the recent 15.8% increase in CRISPR's stock price over the past month, the longer-term underperformance highlights ongoing challenges. The company's significant net losses and decreasing revenue signal potential hurdles to achieving forecasted revenue growth of 57.32% per year. Earnings forecasts remain bleak, as CRISPR is currently unprofitable and not expected to turn profitable within the next three years. This indicates that while the recent uptick in share price might be aligned with short-term market trends, the company's underlying financial health presents uncertainties. Analyst consensus estimates a fair value price target of US$81.67, which is over twice the current share price. This suggests that the stock is trading at a substantial discount, potentially implying room for future price appreciation if the company can improve its financial metrics. However, it also underscores the risks, given the current unprofitable status and forecasted challenges ahead. Examine CRISPR Therapeutics' past performance report to understand how it has performed in prior years. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include NasdaqGM:CRSP. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio


New York Post
9 minutes ago
- New York Post
Trump says Elon Musk will face ‘very serious consequences' if he funds Dems in future elections
WASHINGTON — President Trump warned Saturday that his former ally Elon Musk will face 'very serious consequences' if he starts bankrolling Democratic candidates for office after their nasty public split over a Republican spending bill working its way through Congress. 'If he does, he'll have to pay the consequences for that,' Trump told NBC News' Kristin Welker in an interview. 'He'll have to pay very serious consequences if he does that,' the president added. Advertisement 3 Musk and Trump have been feuding after the Tesla CEO spoke out on the president's 'big beautiful' bill. AP 'Is there anything else you just want people to know about the status,' Welker asked. 'No, not at all. We're doing great,' Trump replied. 'The bill is great. It looks like we're going to get it passed. Looks strongly like we're going to get it passed.' Advertisement 3 Musk was part of cabinet meetings during the first few months of Trump's second term. Molly Riley/White House / SWNS Musk knocked Trump during a multi-day X tirade over the debt increases contained in the 'big beautiful bill' earlier this week and said without his hundreds of millions of dollars in contributions, the president would never have been re-elected in 2024. Here is the latest on Donald Trump and Elon Musk's feud He also claimed credit for delivering the GOP a 53-47 majority in the Senate — and holding onto its majority in the House. Advertisement 3 Trump has hit back at Musk's comments in the ongoing feud. The Tesla and SpaceX billionaire contributed more than a quarter of a billion dollars to Republican candidates in the 2024 cycle, federal campaign filings show.


Gizmodo
9 minutes ago
- Gizmodo
Musk Deletes His ‘Really Big Bomb' Claiming Trump Appears in Epstein Files
In the middle of their very public breakup, a scorned Elon Musk decided to drop a 'really big bomb' on Donald Trump, accusing the president of appearing in the Epstein files. Sometime Saturday, it seems the billionaire decided he wanted to try to disarm that bomb, as he deleted his posts claiming that Trump has links to the famous child sex trafficker. Musk and Trump had been acting catty for a couple of days by the time Musk went nuclear, going back and forth over Musk's opposition to Trump's 'Big Beautiful Bill'—a proposal that includes the largest cuts to Medicaid and food assistance programs in history. Musk objected to the bill, but not because it would be devastating to low- and middle-income households, but seemingly rather because it was going to hurt his own bottom line by ending electric vehicle tax credits that Tesla benefits from. Musk tried to kill the bill by posting incessantly about it, creating a rift among Republicans who will essentially need everyone in the party to be on board in order to get the thing passed. Trump, annoyed, took some shots at Musk for his dissent, which led to Musk just blowing the whole thing up. He said Trump appeared in the Epstein files and 'That is the real reason they have not been made public.' Funnily, he also doubled down by saying, 'Mark this post for the future. The truth will come out.' Those posts are now deleted—though have, of course, been archived, screenshotted, and quoted many times over. So, too, has a post in which Musk supported the idea that Trump should be impeached. He hasn't gotten around to taking down his post claiming that Trump's tariffs will cause a recession, so, it's clear the two aren't fully ready to make up, even if there is a de-escalation. We're also starting to get more of a picture of what has been happening behind the scenes while these two air out each other in public. A report published Saturday by the Washington Post claims that Trump was 'dejected' during Musk's crash out, and tried to rationalize Musk's behavior by calling him 'a big-time drug addict.' Musk had apparently been acting erratically for quite some time (not exactly a shock if you've scrolled through his posts on Twitter for like, 30 seconds), and a reported physical conflict with Treasury Secretary Scott Bessent that saw Musk supposedly throw his shoulder into Bessent was the breaking point where the billionaire started to get pushed out, per the Post. Trump opted not to pour gasoline on the situation—a shocking decision from a guy not exactly known for his restraint—but also is apparently not interested in reconciling with Musk. An official within the administration told the Post that even if they do make up, 'It'll never be the same.'